RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Prophase Labs - Stock

Prophase Labs Net Income 2024

Prophase Labs Net Income

-17.97 M USD

Ticker

PRPH

ISIN

US74345W1080

WKN

A1CYM1

In 2024, Prophase Labs's profit amounted to -17.97 M USD, a 7.08% increase from the -16.78 M USD profit recorded in the previous year.

The Prophase Labs Net Income history

YEARNET INCOME (undefined USD)
2026e77.11
2025e9.34
2024e-17.97
2023-16.78
202218.5
20216.3
2020-2.1
2019-3.1
2018-1.7
201740.6
2016-2.9
2015-3.6
2014-7.8
20130.4
2012-1.1
2011-2.7
2010-3.5
2009-3.8
2008-5.5
2007-2.5
2006-1.7
20053.2
20040.5

Prophase Labs Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Prophase Labs, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Prophase Labs from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Prophase Labs’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Prophase Labs. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Prophase Labs’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Prophase Labs’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Prophase Labs’s growth potential.

Prophase Labs Revenue, Profit, and EBIT History

DateProphase Labs RevenueProphase Labs EBITProphase Labs Net Income
2026e47.32 M undefined119.05 M undefined77.11 M undefined
2025e141.03 M undefined12.97 M undefined9.34 M undefined
2024e48 M undefined-14.29 M undefined-17.97 M undefined
202344.38 M undefined-21.61 M undefined-16.78 M undefined
2022122.6 M undefined23.6 M undefined18.5 M undefined
202179 M undefined9.8 M undefined6.3 M undefined
202014.5 M undefined-4 M undefined-2.1 M undefined
20199.9 M undefined-3.2 M undefined-3.1 M undefined
201813.1 M undefined-1.6 M undefined-1.7 M undefined
20179.9 M undefined-4 M undefined40.6 M undefined
20164.2 M undefined-3.8 M undefined-2.9 M undefined
20152.5 M undefined-2.1 M undefined-3.6 M undefined
201422.1 M undefined-4.2 M undefined-7.8 M undefined
201325 M undefined400,000 undefined400,000 undefined
201222.4 M undefined-2.1 M undefined-1.1 M undefined
201117.5 M undefined-2.7 M undefined-2.7 M undefined
201014.5 M undefined-3.6 M undefined-3.5 M undefined
200919.8 M undefined-3.9 M undefined-3.8 M undefined
200820.5 M undefined-6.7 M undefined-5.5 M undefined
200728.2 M undefined-2.5 M undefined-2.5 M undefined
200626.9 M undefined-1.2 M undefined-1.7 M undefined
200553.7 M undefined3 M undefined3.2 M undefined
200443.9 M undefined200,000 undefined500,000 undefined

Prophase Labs stock margins

The Prophase Labs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Prophase Labs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Prophase Labs.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Prophase Labs's sales revenue. A higher gross margin percentage indicates that the Prophase Labs retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Prophase Labs's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Prophase Labs's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Prophase Labs's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Prophase Labs. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Prophase Labs's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Prophase Labs Margin History

Prophase Labs Gross marginProphase Labs Profit marginProphase Labs EBIT marginProphase Labs Profit margin
2026e36.59 %251.6 %162.97 %
2025e36.59 %9.2 %6.62 %
2024e36.59 %-29.78 %-37.44 %
202336.59 %-48.7 %-37.81 %
202257.67 %19.25 %15.09 %
202153.16 %12.41 %7.97 %
202031.72 %-27.59 %-14.48 %
201926.26 %-32.32 %-31.31 %
201836.64 %-12.21 %-12.98 %
201719.19 %-40.4 %410.1 %
201623.81 %-90.48 %-69.05 %
201532 %-84 %-144 %
201464.25 %-19 %-35.29 %
201366.8 %1.6 %1.6 %
201263.84 %-9.38 %-4.91 %
201164.57 %-15.43 %-15.43 %
201060.69 %-24.83 %-24.14 %
200958.59 %-19.7 %-19.19 %
200855.61 %-32.68 %-26.83 %
200765.96 %-8.87 %-8.87 %
200665.06 %-4.46 %-6.32 %
200551.77 %5.59 %5.96 %
200446.47 %0.46 %1.14 %

Prophase Labs Aktienanalyse

What does Prophase Labs do?

Prophase Labs Inc is a company focused on the development, manufacturing, and marketing of health products. It was founded in 1989 and is headquartered in Doylestown, Pennsylvania, USA. The business model of Prophase Labs is based on developing and selling innovative products in the health and wellness sector. The company specializes in three main areas: medical products, dietary supplements, and women's health through the TheaCare division. Medical products are mainly produced for the over-the-counter (OTC) market. OTC products are sold directly to consumers without a prescription. Prophase Labs offers products for pain relief, cough and cold, and sleep disorders. Dietary supplements are also distributed under the Cold-Eeze brand. The company offers various products such as gums, lozenges, and syrups for the treatment of cold and flu symptoms. These products are available in the USA and Canada. Prophase Labs' TheaCare division specializes in women's health. The products range from hygiene items to menstrual pain relievers to supplements for menopause. One well-known product is Zicam, a nasal spray designed to reduce cold and flu symptoms. It has been manufactured by Prophase Labs since 1999. The company has also dealt with the Federal Drug Administration (FDA) and other regulatory agencies in the past. In 2009, the company had to pay a fine for distributing unauthorized medications. In 2018, Prophase Labs changed its strategy to focus on developing dietary supplements and medical products for the health and wellness market. The company plans to increase its online distribution and expand its sales activities to other countries. The current challenges for Prophase Labs include competition from large pharmaceutical companies and other health sector companies. The industry is heavily regulated, which can make it difficult to introduce new products and expand into new markets. Additionally, the company is also facing declining revenues in some business areas. Overall, Prophase Labs is a company specializing in the manufacturing and sale of health products. With its various divisions and products, the company has the opportunity to reach customers in different areas. Despite facing challenges, it remains an important player in the health and wellness market. Prophase Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Prophase Labs's Profit Margins

The profit margins of Prophase Labs represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Prophase Labs's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Prophase Labs's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Prophase Labs's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Prophase Labs’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Prophase Labs Stock

How much profit has Prophase Labs made this year?

Prophase Labs has made -17.97 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 7.08% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Prophase Labs publish its earnings?

Prophase Labs publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Prophase Labs?

The profits of Prophase Labs are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Prophase Labs?

You can learn more about the earnings of Prophase Labs by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Prophase Labs pay?

Over the past 12 months, Prophase Labs paid a dividend of 0.6 USD . This corresponds to a dividend yield of about 14.08 %. For the coming 12 months, Prophase Labs is expected to pay a dividend of 0 USD.

What is the dividend yield of Prophase Labs?

The current dividend yield of Prophase Labs is 14.08 %.

When does Prophase Labs pay dividends?

Prophase Labs pays a quarterly dividend. This is distributed in the months of January, June, March, June.

How secure is the dividend of Prophase Labs?

Prophase Labs paid dividends every year for the past 2 years.

What is the dividend of Prophase Labs?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Prophase Labs located?

Prophase Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Prophase Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Prophase Labs from 6/3/2022 amounting to 0.3 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2022.

When did Prophase Labs pay the last dividend?

The last dividend was paid out on 6/3/2022.

What was the dividend of Prophase Labs in the year 2023?

In the year 2023, Prophase Labs distributed 0.6 USD as dividends.

In which currency does Prophase Labs pay out the dividend?

The dividends of Prophase Labs are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Prophase Labs

Our stock analysis for Prophase Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prophase Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.